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The distinguishing feature of adult stem cells
is their extraordinary capacity to divide prior
to the onset of senescence. While stratified ep-
ithelia such as skin, prostate, and breast are
highly regenerative and account disproportion-
ately for human cancers, genes essential for the
proliferative capacity of their stem cells remain
unknown. Here we analyze p63, a gene whose
deletion in mice results in the catastrophic
loss of all stratified epithelia. We demonstrate
that p63 is strongly expressed in epithelial cells
with high clonogenic and proliferative capacity
and that stem cells lacking p63 undergo a pre-
mature proliferative rundown. Additionally, we
show that p63 is dispensable for both the com-
mitment and differentiation of these stem cells
during tissue morphogenesis. Together, these
data identify p63 as a key, lineage-specific de-
terminant of the proliferative capacity in stem
cells of stratified epithelia.
INTRODUCTION
A defining feature of adult stem cells is their immense ca-
pacity for self-renewal while avoiding the immortality of
neoplastic cells. Deciphering the molecular basis of this
self-renewal process will be important for both regenera-
tive medicine and understanding how this process con-
tributes to tumorigenesis. Recent advances have high-
lighted the existence of essential, lineage-restricted
regulators of self-renewal programs for hematopoietic,
neural, and spermatogonial stem cells (Lessard and Sau-
vageau, 2003; Molofsky et al., 2003; Park et al., 2003;
Buaas et al., 2004; Costoya et al., 2004). Despite these
discoveries, a corresponding master regulator of the
highly regenerative stratified epithelia, which give rise to
most human cancers, remains elusive. p63, a homolog
of the p53 tumor suppressor gene, has been implicatedin the morphogenesis and maintenance of all stratified
epithelia, including breast, prostate, skin, and urothelia
(Yang et al., 1999, 2002). Loss-of-function mouse models
for p63 have revealed a dramatic epithelial phenotype dur-
ing embryogenesis marked by the loss of these tissues
that normally express high levels of p63 in their stem cell
compartments (Mills et al., 1999; Yang et al., 1999). As
such, p63 was among the first genes proposed to function
in the maintenance of stem cell populations (Yang et al.,
1999). However, others have concluded that p63 func-
tions in pathways of epithelial lineage commitment and/
or differentiation (Mills et al., 1999; Koster et al., 2004;
Truong et al., 2006). These discrepancies have contrib-
uted to a controversy surrounding p63’s biological func-
tion whose resolution will have important implications for
not only epithelial morphogenesis and regeneration but
mechanisms of tumorigenesis as well.
In this work, we examine the basis of thymic and epider-
mal dysgenesis in p63 null mice to further probe the func-
tion of p63 in epithelial stem cells. We show here that p63
is not required for lineage commitment and differentiation
of epithelial cells, as these cells present the typical
markers for epithelial development and, in the case of
the thymic epithelia, are fully competent to support the
maturation of developing T cells in the thymus. We find,
instead, that p63 specifically functions to maintain the
extraordinary proliferative capacity of the epithelial stem
cells of the thymus and epidermis. These data suggest a
general function of the p63 transcription factor in maintain-
ing the stem cells of a broad array of stratified epithelia.
RESULTS
Loss of p63 Leads to an Unusual Thymic Hypoplasia
Our interest in the thymus for the analysis of p63 function
was driven by the high p63 expression in thymic epithelial
cells (Di Como et al., 2002; Chilosi et al., 2003) and the
ability to investigate the cooperative interactions between
these epithelial cells and the lymphoid cells during thymic
development. In particular, the development of thymic
lymphocytes serves as a good indicator for the functionalCell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc. 523
maturation of epithelial components in the thymus (van
Ewijk et al., 2000; Anderson and Jenkinson, 2001; Gill
et al., 2003; Blackburn and Manley, 2004).
The thymic epithelial precursor cells are derived from
the endoderm of the third pharyngeal pouch (Gordon
et al., 2004) and appear at embryonic day 12 (E12) as
a cluster of approximately 1000 cells that uniformly ex-
press high levels of p63 and the epithelial marker keratin
8 (K8) (Figure 1A). p63-positive epithelial cells are also
found at later stages of development in both the thymic
cortex and medulla (Figure 1B; see also Figure S1 in the
Supplemental Data available with this article online), con-
sistent with recent findings that a common stem cell pre-
cursor gives rise to both compartments (Bleul et al., 2006;
Rossi et al., 2006). Given the high expression of p63 in
what appear to be thymic epithelial precursor cells, we
asked whether the loss of p63 in p63 knockout mice would
affect thymic morphogenesis. To do this, we examined
thymic development during embryogenesis of wild-type
and p63 null mice. The p63 null embryos exhibited
a marked thymic hypoplasia compared with the wild-
type or p63 heterozygous embryos at birth (Figure 1C).
We examined the constituent cell types of these hypoplas-
tic thymuses and found that both the T cells and the thy-
mic epithelial cells were present, albeit at about 10% of
their normal numbers (Figures S2 and S3). Thus, unlike
mice with other genetic defects leading to thymic hypo-
plasia, such as the Nude mouse having mutations in
Foxn1 or mice lacking the recombination-activating
(Rag) genes, in which thymic development is halted at
a precise developmental time (Blackburn et al., 1996;
Nehls et al., 1996; Klug et al., 2002), the p63 null thymus
continues to grow, albeit at a progressively slower rate
(Figure 1D). This unusual pattern of thymic hypoplasia
suggested a unique function of p63 in thymic epithelial
cells. In principle, the defect leading to the hypoplasia
could be in either the lymphoid or epithelial component
of the thymus, affecting any stage of precursor commit-
ment, stem cell regeneration, or the proliferation or differ-
entiation of these lineages (Figure 1E). Significantly, the
observed thymic hypoplasia parallels the embryonic de-
mise of other epithelial tissues in p63 null mice such as
skin, breast, and prostate (Mills et al., 1999; Yang et al.,
1999). Unlike the p63 null epidermis, however, which we
proposed to undergo a nonregenerative differentiation
and disintegrate into the amniotic fluid, the p63 null hypo-
plastic thymus remains intact and therefore offers a unique
opportunity to address the normal function of p63 in epi-
thelial morphogenesis. Consistent with these parallels,
the predominant p63 isoform expressed in thymic epithe-
lial cells, DNp63a (hereafter DNp63), is identical to that
expressed in stem cells of other stratified epithelial tissues
(Figure S4) (Yang et al., 1998; Signoretti et al., 2000;
Nylander et al., 2002).
We next asked whether the lymphoid component of the
thymus contributed to the thymic hypoplasia in the p63
null mouse. To do this, we reconstituted Rag2-deficient
mice, which lack mature B and T cells (Shinkai et al.,524 Cell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc.1992), with fetal hematopoietic stem cells derived from
p63 null mice (Figure 2A). Significantly, hematopoietic cells
lacking p63 restored normal thymic development in the
Rag2-deficient mice, as evidenced by the normal numbers
and differentiation profiles of CD4+ helper and CD8+ cyto-
toxic T cell populations (Figures 2B and 2C; Senoo et al.,
Figure 1. Expression of p63 and Thymic Hypoplasia in p63
Null Embryos
(A) Distribution of p63-expressing thymic epithelial cells in the E12.0
thymus. Scale bars in (A) and (B) = 50 mm.
(B) Distribution of p63-expressing epithelial cells in the medulla (left)
and cortex (right) regions in wild-type newborn thymus. Asterisks
denote p63-negative epithelial cells, while arrowheads point to the
p63-positive epithelial cells in the cortex.
(C) Gross appearance of the thymus and heart of E19.5 wild-type (+/+),
p63 heterozygous (+/), and p63 null (/) mice.
(D) Growth of the thymus during embryogenesis. Thymic volume was
estimated by the equation 4p/3 3 ([RL + RS]/2)
3, where RL and RS
were the largest and the smallest radius of the thymus, respectively.
Data are presented as the mean ± SD from three independent exper-
iments.
(E) Cellular events in thymic development including lineage commit-
ment, differentiation, proliferation, and self-renewal of stem cells.
Figure 2. Differentiation of Thymic Epithelial Cells in the Absence of p63
(A) Scheme of thymic T cell reconstitution by adoptive transfer.
(B) Total number and development of reconstituted thymic T cells.
(C) Proliferation responses of wild-type and p63 null T cells following stimulation with anti-CD33 antibodies, expressed as the mean ± SD from three
independent experiments.
(D) Initiation of p63 expression in the third pharyngeal pouch. Bottom left: hematoxylin and eosin staining; I–IV, branchial arches. Top right: K8 staining
of the green boxed area at bottom left; Th, thymic anlage; Pt, parathyroid. Bottom right: p63 staining in the corresponding region. Arrowheads indicate
the initiation of p63 expression in the thymic anlage. Scale bar = 50 mm.
(E) Appearance of the thymic anlage at E11.0. pc3, third pharyngeal cleft. Scale bar = 100 mm.
(F) Top: expression of thymic epithelial markers in E15.5 embryos. Insets: representative images of medullary epithelial cells (M) labeled by UEA-1.
Scale bar = 250 mm. Bottom: in vitro culture of thymic epithelial cells. Scale bar = 50 mm.
(G) FACS profile of thymic T cell development. Inset numbers refer to percentages of total T cells in quadrant.
(H) T cell receptor a and b chain expression in thymic T cells from newborn mice.
(I) DNA microarray analysis of E18 thymus. Two-dimensional scatter plots of gene expression are shown for the T cell developmental markers and for
all of the genes (inset).Cell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc. 525
2004) and the normal proliferative responses of these
cells to T cell receptor activation (Figure 2C). These data
argue against a T cell-autonomous role of p63 in thymic
T cell development and favor an epithelial cell defect as
the primary cause of thymic hypoplasia in the p63 null
mouse.
p63 Is Dispensable for Lineage Commitment
and Differentiation in the Thymus
Having attributed the defect in p63 null mice to the epithe-
lial compartment, it was important to determine the mech-
anistic basis for the observed thymic hypoplasia. As
mentioned earlier, defects in lineage commitment, differ-
entiation, proliferation, or stem cell renewal could underlie
thep63mutant phenotype (Figure 1E). To address whether
p63 was required for the early development of the thymus,
we examined the thymic anlage in the third pharyngeal
pouch of E10.5 embryos. Significantly, the thymic primor-
dia contain cytokeratin-positive cells that are only weakly
expressing p63, indicating that epithelial cells form the thy-
mic anlage ahead of significant p63 expression (Figure 2D).
Moreover, in E11 embryos, the appearance of the thymic
anlage in the p63 null animals is similar to that of the
wild-type littermates (Figure 2E), indicating these early
morphological events in the thymus are independent of
p63. We next examined older, E15.5 embryos for the ex-
pression of the epithelial lineage markers keratin 8 (K8)
and keratin 5 (K5) (Klug et al., 2002), as well as those rec-
ognizing Ulex europaeus agglutinin 1 (UEA-1), a lectin
that binds mature medullary thymic epithelia (Anderson
and Jenkinson, 2001). The expression pattern of these
markers was indistinguishable between wild-type and
mutant thymuses (Figure 2F, top). We also assessed K8
and K5 markers of thymic epithelial cells grown in culture.
Consistent with the in vivo data, both wild-type and p63
null thymic epithelial cells showed comparable frequen-
cies of K5+, K8+, and K5+K8+ cells (Figure 2F, bottom).
Together with an analysis of a wide range of markers
using antibodies and expression microarrays (Table S1),
these results indicate that thymic epithelial cells execute
commitment and differentiation programs in the absence
of p63.
It is well established that thymic epithelial differentiation
is necessary for the multiple steps of T cell differentiation
in the thymus (van Ewijk et al., 2000; Anderson and Jenkin-
son, 2001; Gill et al., 2003; Blackburn and Manley, 2004).
Therefore, if p63-deficient thymic epithelial cells were
capable of supporting T cell development, this would
provide strong, functional evidence for their ability to
undergo epithelial commitment and differentiation. In-
deed, we found that T cells in the p63 null thymus progress
normally through development as evidenced by CD4,
CD8, and T cell receptor expression (Figures 2G, 2H).
Moreover, gene expression microarrays with wild-type
and p63 null littermate thymuses revealed very similar ex-
pression patterns of genes associated with T cell develop-
ment (Figure 2I). Thus, in contrast to the Nude mouse,
which exhibits defects in thymic epithelial differentiation526 Cell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc.and consequently fails to support thymic T cell develop-
ment, p63 null mice show normal T cell development,
consistent with the concept that p63 is not required for
functional maturation of thymic epithelial cells.
p63 Is Essential for Proliferative Potential of Thymic
Epithelial Stem Cells
Having ruled out obvious defects in epithelial commitment
and differentiation in thymic epithelia lacking p63, we
compared the ability of isolated thymic epithelial cells to
form colonies in three-dimensional suspension cultures
in vitro (Figures 3A–3D). The cells were grown in a nutrition-
ally optimized serum-free medium, which selectively per-
mits epithelial cells to grow (Kolly et al., 2005). By day 10,
wild-type cells yielded large colonies consisting of tightly
packed cells expressing epithelial markers including
cytokeratins and p63 (Figures 3B and 3C). p63-deficient
cells also yielded colonies expressing cytokeratins but
had only one-tenth the number of cells found in wild-
type colonies (Figures 3A, 3B, and 3D). This difference
became greater with time, such that by day 15, the mutant
clones had less than one-seventeenth the number of
cells seen in the wild-type clones (Figure 3D). The de-
crease in the three-dimensional growth of the p63 null
clones suggested a role for p63 in either the rate of prolif-
eration or the overall proliferative potential of the epithelial
cells.
To test whether p63 played a role in proliferation per se,
we examined proliferation of thymic epithelial cells during
embryogenesis using both in utero bromodeoxyuridine
(BrdU) incorporation (Figures 3E–3H) and Ki67 staining
(Figure S5). Significantly, from histological sections, we
could not detect differences in E13 wild-type and p63
null thymuses in the percentage of K8-positive cells that
incorporated BrdU (Figures 3E and 3F). Similarly, fluores-
cence-activated cell sorting (FACS) on dissociated thy-
mus from E18 embryos using the Ly51 epithelial cell
marker (Adkins et al., 1988) revealed similar rates of
BrdU incorporation in the wild-type and p63 null epithelial
cells (Figures 3G and 3H). These data are consistent with
the notion that the rate of proliferation of thymic epithelial
cells is not affected by p63 status.
We then asked how the de novo loss of p63 would affect
the clonogenicity of thymic epithelial stem cells in vitro. To
do this, we first had to establish a system to support the
clonal growth of thymic epithelial stem cells, as they
have eluded previous cloning strategies. Given the re-
markable success of methods developed by Green and
colleagues to clone and propagate stem cells of the epi-
dermis and the corneal epithelia for use in therapeutic
transplants (Barrandon and Green, 1985; 1987; Pellegrini
et al., 2001; De Luca et al., 2006), we adapted that system
to the thymic epithelial stem cells. With only minor modifi-
cations, we found that this system would readily support
the propagation of clones of rat thymic epithelia from sin-
gle cells (Figure 4A). Importantly, 94% of the cells of these
epithelial clones expressed high levels of p63 after two
weeks of culture even though they were derived from
Figure 3. Clonogenic Analysis and Proliferation of Thymic Epithelial Cells
(A) Phase-contrast images of typical three-dimensional colonies formed by thymic epithelial cells derived from E17 wild-type (+/+) and p63 null (/)
embryos. Scale bar in (A) and (B) = 30 mm.
(B) Whole-mount immunofluorescence of three-dimensional clones at day 15 with anti-K8 and anti-K5 antibodies.
(C) Left: immunofluorescence with K5 and K8 antibodies on a section of a wild-type day 15 clone. Right: corresponding image with anti-p63 antibody
and counterstained with DAPI. Scale bar in (C) and (E) = 50 mm.
(D) Comparison of the epithelial clone growth over time.
(E) Proliferation of the E13 thymic epithelial cells following in utero labeling with BrdU. Tissue sections were stained with anti-BrdU (red) and anti-K8
(green) antibodies and counterstained with DAPI.
(F) Quantification of (E). The percentages of BrdU+/K8+ cells are expressed as the mean ± SD from three independent experiments.
(G) Top: FACS analysis of E19 thymus following an in utero pulse with BrdU. Numbers are the percentages of the cells in each quadrant. Bottom:
histogram showing the frequency of the BrdU+/Ly51+ epithelial cells.
(H) Quantification of M1 fractions in (G), expressed as the mean ± SD from four independent experiments.thymuses where only 1% of the epithelial cells were
strongly p63 positive (Figures 4B and 4C). In addition,
the cells in these clones appeared morphologically imma-
ture and undifferentiated (Figure S6) and could be taken
through multiple passages over six months without under-
going transformation (data not shown). Together with data
from other epithelia (De Luca et al., 2006), these results in-
dicate that p63 is a marker of thymic epithelial stem cells.
Having established this clonogenic assay for thymic ep-
ithelial stem cells, we asked how the de novo loss of p63
would affect clonal growth. The p63-expressing thymic
epithelial stem cells were transduced with lentiviruses en-
coding enhanced green fluorescent protein (EGFP) along
with control and p63-specific shRNAs (Figure 4D), the lat-ter of which reduced p63 protein levels to less than 5% of
that of control cells (Figure 4E). Both sets of transduced
cells were then assessed for clonogenicity based on clone
size over time. Colonies derived from single thymic epithe-
lial stem cells transduced with control and p63 shRNAs
were compared at 8, 12, and 20 days of growth. At day
8, those expressing the p63 shRNA showed a tendency
to form smaller colonies than those expressing control
shRNAs, and this trend became more obvious in the 12
and 20 day cultures (Figures 4F–4H). Corresponding to
the loss of proliferative potential in the thymic epithelial
clones, we observed similar staining for the Ki67 prolifer-
ation marker in the control and p63 shRNA-expressing
clones at day 8, but the p63 shRNA-expressing clonesCell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc. 527
Figure 4. p63 and Proliferative Potential
in Thymic Epithelial Stem Cells
(A) Gross appearance of rhodamine B-stained
thymic epithelial clones at indicated days after
plating. Scale bar = 1 cm.
(B) Enrichment of highly p63-positive epithelial
cells during in vitro expansion. Dissociated sin-
gle cells from 3-week-old rat thymus (top) were
plated on 3T3-J2 feeder cells for 10 days (bot-
tom). Data shown are gated on cytokeratin-
positive epithelial populations. Insets: control
staining (green).
(C) Example of a day 10 clone stained with an
anti-p63 antibody. Scale bar = 200 mm.
(D) Phase-contrast and fluorescence imaging
of thymic epithelial cells transduced with lenti-
viruses driving control (left) and p63-directed
(right) shRNAs and GFP. Transduction efficien-
cies (%) are indicated in the lower panels. In-
sets are representative images of the trans-
duced cells stained with anti-p63 antibody
and counterstained with DAPI. Scale bar =
50 mm.
(E) Western blot of the cells in (D).
(F) Distribution of the clones at day 12 of culti-
vation. Representative size of each subclass
is shown by GFP fluorescence, and the per-
centages refer to the frequency of the clones
in each subclass. Scale bar = 1 mm.
(G) Comparison of the clone growth plotted on
a logarithmic scale.
(H) Relative clone growth over time.
(I) Loss of proliferation in p63 knockdown
clones during long-term culture. Representa-
tive clones among the largest subclasses,
stained with anti-Ki67 antibody and counter-
stained with DAPI, are shown. Scale bars =
100 mm.
(J) Increased incidence of the terminal differen-
tiation marker involucrin in the late p63 knock-
down clones. Shown are representative day 12
clones, stained with anti-involucrin antibody
and counterstained with hematoxylin to visual-
ize the nuclei. Scale bar = 50 mm.
(K) Quantification of involucrin expression by
western blot.showed significantly fewer Ki67-positive cells at day 20
(Figure 4I). Finally, cells in the control clones appeared
small and immature, whereas those expressing the p63
shRNA were large and showed increased incidence of ex-
pression of the terminal differentiation marker involucrin
(Figures 4J and 4K). These findings are supported by
data from the analysis of wild-type and p63 null thymuses
in vivo. Comparison analysis of DNA microarray expres-
sion data showed that the relative balance between imma-
ture cells (i.e., K14/K17-positive cells) and terminally dif-
ferentiated cells (i.e., involucrin/occludin/claudin-positive
cells; Langbein et al., 2003) was biased toward the latter
in p63 null thymus in more advanced stages of embryonic
development (Figure S8; Table S1). These results are con-
sistent with a primary role for p63 in the maintenance of
the high proliferative potential of epithelial stem cells.528 Cell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc.Thymic Hypoplasia: Epithelial Cell Apoptosis
and Clearance
We reasoned that if the rates of proliferation are not al-
tered in the p63 null thymic epithelia in vivo (Figures 3E–
3H) and yet p63 appeared to be essential for proliferative
potential, then the thymic hypoplasia must be due to a pre-
mature replicative rundown of the epithelial cells coupled
with a means of continuously clearing those cells from the
thymus. We therefore asked whether there were differen-
tial rates of apoptosis in the wild-type and p63 null thymic
epithelia. We first examined annexin V staining, an early
marker of apoptosis, among populations of E18 wild-
type and p63 null thymic cells by FACS analysis
(Figure 5A). While the T cells showed a similar profile of an-
nexin V staining in the wild-type and mutant thymuses, the
p63 null epithelial cells showed a 2-fold increase in cells
Figure 5. Apoptosis andClearance of p63Null Thymic Epithe-
lial Cells
(A) Increased apoptosis in p63 null thymic epithelial cells. Histograms
of annexin V staining on E18 thymic epithelial cells (TEC) and T cells in
wild-type (+/+) and p63 null (/) thymuses are shown. Bar graphs
show quantification of the histograms, expressed as the mean ± SD
from six independent experiments.
(B) Increased apoptosis in p63 knockdown thymic epithelial clones at
day 20 of cultivation. Right: quantification of annexin V+ fraction, ex-
pressed as the mean ± SD from three independent experiments. C,
control; sh, p63 shRNA.
(C) Increased engulfment by macrophages of thymic epithelial cells
in p63 null thymus. Sections of E18 thymuses were double stained
with the macrophage marker F4/80 (green) and anti-cytokeratin (red)that were annexin V positive (16.8% ± 1.5% in wild-type
thymus; 36.7% ± 2.1% in p63 null thymus). Consistent
with this finding, thymic epithelial clones derived from
cells transduced with p63 shRNA lentiviruses in vitro
also showed a similar increase in annexin V-positive cells
compared to control clones at day 20 of cultivation
(Figure 5B). One interpretation of these data is that this in-
crease in annexin V staining among the p63-deficient thy-
mic epithelial cells reflects their impending loss from the
proliferative cell population. Consistent with this increase
in apoptotic or proapoptotic epithelial cells in p63 null thy-
mus, we noted an increase in thymic macrophages that
appeared to colocalize with these epithelial cells (Fig-
ure 5C). This observation supports the notion that p63
null epithelial cells undergo higher rates of cell death and
are cleared by macrophages. To evaluate the efficiency
of clearance by phagocytosis, we then examined TUNEL
staining, a marker of late apoptosis involving the labeling
of the degraded DNA fragments. While we detected an in-
crease in TUNEL-positive cells in the mutant thymus, the
overall percentage of TUNEL-positive cells in both p63
null and wild-type cells was very small (less than 2%;
Figure 5D). This suggests that an efficient mechanism of
clearance of apoptotic cells exists in the mutant thymus.
These results support the conclusion that enhanced apo-
ptosis and clearance of epithelial cells explains why prolif-
eration rates were not changed in p63 null epithelial cells
during thymic development despite the obvious thymic
hypoplasia. They also indicate that the overall mechanism
of thymic hypoplasia in the p63 null mouse is distinctly dif-
ferent from that of either the Nude mouse or those with
mutations in the Rag genes. In Nude mice, the thymus
never advances beyond the primordial thymic anlage
due to mutations in Foxn1, a gene essential for thymic
epithelial differentiation. Thus, the Nude thymic epithelial
progenitor cells, which express p63 (data not shown), do
not progress to mature cells capable of interactions with
thymic T cells. Similarly, Rag mutations prevent T cell re-
ceptor rearrangements and thus the subsequent prolifer-
ation of the lymphoid population essential for thymic
growth, leaving thymic development arrested in a hypo-
plastic state (Blackburn et al., 1996; Nehls et al., 1996;
Klug et al., 2002).
Generalization of p63’s Role in Stratified Epithelia:
Epidermal Stem Cells
p63 is also expressed in the stem cells of skin, breast, and
prostate (Yang et al., 1998; McKeon, 2004). Given our
finding that p63 is essential for the proliferative potential
of thymic epithelial stem cells, we asked whether epider-
mal stem cells share a similar requirement for p63. To do
antibodies. Insets: enlarged views of the boxed area. Scale bar in (C)
and (D) = 50 mm.
(D) TUNEL staining of E14.5 thymus. TUNEL-positive cells appear in
red, while epithelial cells are marked by anti-cytokeratin antibody
(green). Bottom: quantification of the TUNEL-positive epithelial cells,
expressed as the mean ± SD from three independent experiments.Cell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc. 529
Figure 6. Localization and Loss of Function of p63 in the Epidermis
(A) Distribution of p63 in the epidermis. Immunofluorescence of 1-week-old rat epidermis stained with anti-p63 and anti-cytokeratin antibodies in the
interfollicular epidermis (1) and in the bulge of the hair follicle (2) is shown. Scale bars = 25 mm.
(B) Gross appearance of E18 wild-type (+/+) and p63 null (/) embryos highlighting the face and torso.
(C) Immunofluorescence of transverse sections through the torso of E16 embryos using antibodies to K5 (green) and cytokeratin (red) and counter-
stained with DAPI (blue). Scale bars = 1 mm.
(D) Immunofluorescence of the epidermis of E16 wild-type (top) and p63 null (bottom) embryos stained with antibodies to K5 (left panels) and the
epidermal terminal differentiation marker loricrin (right panels). Scale bars = 50 mm.this, we first examined how p63 expression was related to
previous localizations of stem cells within the epidermis.
The in situ localization of epidermal stem cells has been
deduced from microdissections and clonogenic assays,
which indicated that they cluster in the bulge of the hair fol-
licle, with lesser numbers in the interfollicular epidermis
and the hair bulb (Oshima et al., 2001; Lavker et al.,
2003; Claudinot et al., 2005; Levy et al., 2005). Immunoflu-
orescence localization of p63 expression in rat epidermis
with optimal dilutions of the 4A4 anti-p63 monoclonal an-
tibody revealed that p63 is highly expressed in the bulge
region of the follicle and expressed intermittently along
the interfollicular epidermis (Figure 6A).530 Cell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc.Having established a correlation between p63 expres-
sion and epidermal stem cells, we next asked whether
p63 was essential for the commitment or differentiation
of these cells from primitive ectoderm, a process that be-
gins at E13. We therefore examined morphogenesis of
wild-type and p63 null epidermis during embryogenesis.
In comparing the surface features of these littermates, it
was evident that the wild-type embryos displayed a con-
tinuous epidermis (Figure 6B, upper panel). In contrast,
the p63 null embryos had only fragments of the epidermis
that appeared to be peeling off the surface even though
they were isolated by careful cesarean sectioning (Fig-
ure 6B, lower panel). This impression was borne out by
histological examination of transverse sections of these
embryos, which revealed a fully intact stratified epidermis
on the surface of wild-type animals but a discontinuous
and fragmented appearance in the p63 null animals
(Figure 6C). Despite these differences, antibodies to
markers of immature, committed epidermal cells such as
keratin 5 and differentiated epidermal cells such as loricrin
yielded similar results in these transverse sections through
wild-type and p63 null embryos (Figure 6D). Thus, these
results suggest that the tufts of cells remaining on the sur-
face of the mutant embryos are committed to an epider-
mal lineage that can progress through differentiation.
p63 Is Required for the Proliferative Potential
of Epidermal Stem Cells
To test whether p63 was also required by epidermal stem
cells for extended proliferative potential, we used the clo-
nogenic procedures developed for therapeutic epidermal
stem transplants on rat epidermis, which generated
clones similar to those labeled as holoclones, meroclones,
and paraclones from human epidermis (Figure 7A). The
holoclone-like clones were composed of small, immature
cells that all showed intense nuclear staining with the anti-
p63 monoclonal antibody (Figure 7B). In contrast, the mer-
oclone-like clones contained larger cells toward the clone
center that stained weakly with the p63 antibody. Finally,
paraclone-like clones consisted of very large cells that
generally lacked detectable p63 expression. These data
are consistent with those of corneal epithelial stem cell
clones employed in corneal stem cell transplants and sug-
gest a link between p63 expression and clones with high
proliferative potential (De Luca et al., 2006).
To directly address the role of p63 in the proliferative
potential of epidermal stem cells, we transduced these
cells with lentiviruses driving expression of GFP and an
shRNA directed against p63 transcripts (Figures 7C–7F).
By immunofluorescence, p63 expression was markedly
reduced in the cells transduced by the p63 shRNA-
expressing lentivirus versus those transduced with a con-
trol lentivirus, and by western blot, p63 was reduced by
greater than 90% (Figures 7C and 7D). In accord with
studies on thymic epithelial cells, the clonal size at 7
days was similar among the p63 and control shRNA
groups (Figures 7E and 7F). By 10 and 14 days, those lack-
ing p63 were, on average, smaller than their control coun-
terparts, all falling into the lower two size categories at
those times (Figures 7E and 7F).
Significantly, this effect of p63 shRNAs on rat epidermal
keratinocytes was reproduced in clones of immature hu-
man epidermal keratinocytes (Figure S7), typically used
for stem cell transplants for burn patients (Barrandon
and Green, 1987; De Luca et al., 2006), suggesting that
p63 is also essential to maintain the proliferative potential
of these cells. In addition, this apparent loss of proliferative
potential was only observed with shRNAs that caused
strong suppression of p63 protein expression (Figure S7),
indicating that the loss of p63, and not an off-target effect,
was the basis for the observed effect. While the demiseFigure 7. p63 and the Proliferative Potential of Epidermal
Stem Cells
(A) Rhodamine B-stained epidermal cell clones generated from rat epi-
dermis grown for 10 days on irradiated feeder cells. H, holoclone; M,
meroclone; P, paraclone. Scale bar = 1 cm.
(B) Phase and anti-p63 immunofluorescence and DAPI counterstain-
ing of representative clones for each category at 10 days of cultivation.
Scale bar = 100 mm.
(C) Immunofluorescence of epidermal stem cells transduced with len-
tiviruses expressing control and p63 shRNAs harboring internal GFP.
Scale bar = 50 mm.
(D) Quantification of p63 expression in the cells shown in (C) by western
blot.
(E) Representative appearance and percentages of clones in each
subclass at day 10. Scale bar = 1 mm.
(F) Histograms showing the size distribution of clones expressing con-
trol (white bars) and p63 shRNA (black bars) over time.Cell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc. 531
of the epidermis in the p63 null embryos could be the
result of p63’s regulation of adhesion molecules (Carroll
et al., 2006; Yang et al., 2006), the lack of obvious
adhesion problems in our clonogenic assays suggested
that other mechanisms are operating as well. Overall,
our data from epidermal stem cells from two species
support the conclusion reached from analyses of thymic
epithelia that p63 functions in maintaining proliferative
potential.
Modeling p63 Function
The data presented here support a general model
whereby p63 is required for the very high proliferative po-
tential characteristic of epithelial stem cells that give rise
to, via asymmetric divisions, daughter stem cells and cells
with more limited proliferative potential (nominally transit-
amplifying [TA] cells; Watt, 2001) (Figure 8A). TA cells con-
tinue to divide and yet are closer to senescence and give
rise to cells with progressively less proliferative potential.
Because the thymus remains intact in the p63 null em-
bryos, our modeling has focused on this rather than the
disintegrating epidermis, although the basic concepts
are likely to be relevant to both.
In the simplest model, these TA cells divide at a con-
stant, faster rate than the true stem cells, which in turn
show a progressive decrease in proliferation over time
during embryogenesis (Figures 8B and 8C). This gradual
decrease in stem cell proliferation is estimated to be
10% per day of embryonic growth. In the p63 null mice,
the thymic epithelial progenitors undergo normal prolifer-
ation yet possess a proliferative potential similar to that of
TA cells. Therefore, the entire thymic epithelial population
of the p63 null mice has inherently less proliferative poten-
tial than that of the wild-type animals. In an effort to model
thymic growth in p63 null embryos from its earliest incep-
tion at E10, we assumed a rate of cell division every 24 hr
taking into account a differential loss (D) of thymic epithelia
at each division via senescence and apoptosis. In basic
terms, the relative growth of the thymus can be described
by the equations fwt = 0.9 3 2
n + 0.1n + 0.1 and fp63 null =
2n 3 (1  D)n, where n is the division number (Figure 8D).
This model predicts that a differential loss of 20% of the
p63 null epithelial cells over wild-type cells at each division
would have a dramatic effect on thymic volume. In fact,
this prediction matches well with our actual observations
of thymic epithelial growth in vivo (Figure 8D, inset).
Although this assumption depends on the kinetics of cell
division, our modeling of the observed ratios of thymic
growth during embryogenesis of the wild-type and p63
null embryos independently reveals a differential cell loss
of 15%–26% (D = 0.15–0.26) using a span of cell division
numbers (n = 8–15) corresponding to replication every 16
to 30 hr (Figure 8E). These models show a striking coher-
ence with the decreased growth of the p63 null thymuses
and suggest that cell loss, secondary to their loss of pro-
liferative potential, provides a mechanism for the thymic
hypoplasia in these embryos.532 Cell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc.DISCUSSION
The p63 loss-of-function phenotype in stratified epithelia
parallels those of two other genes that have been impli-
cated in the proliferative potential of stem cells of other lin-
eages. Mice lacking Bmi-1, for instance, are born with
a fully differentiated and functional hematopoietic system
that fails within 30 days due to the proliferative rundown
of hematopoietic stem cells (van der Lugt et al., 1994;
Lessard and Sauvageau, 2003; Park et al., 2003). A related
phenotype is evident in the testes of mice lacking Plzf,
a transcription factor expressed in spermatogonia. Plzf
null mice are fully fertile at the onset of puberty but gradu-
ally lose spermatogenic function due to a depletion of
spermatogonia (Buaas et al., 2004; Costoya et al., 2004).
Thus, a common feature of the loss of Bmi-1, Plzf, and
p63 is the demise of fully committed and differentiated
lineages.
As a member of the p53 family of transcription factors,
p63 is likely to carry out this function via the control of
genes that confer stem cell properties. In this manner,
p63 may also parallel Bmi-1 and Plzf, which are thought
to mediate proliferative potential through various gene
transcription and silencing programs. Bmi-1, for instance,
is a member of the Polycomb family of proteins implicated
in the activation or repression of Hox genes during devel-
opment and adult life (Schumacher and Magnuson, 1997;
Valk-Lingbeek et al., 2004). Bmi-1 has also been impli-
cated in the suppression of p16INK4A (Jacobs et al.,
1999), suggesting that it promotes proliferative potential,
in part, by forestalling pathways of senescence. Plzf is
thought to encode a transcriptional repressor, suggesting
that gene silencing is an important aspect of stem cell
maintenance programs. It may therefore be significant
that DNp63, the predominant p63 isoform in stem cells
of stratified epithelia, can act as both a transcriptional re-
pressor and activator toward a large set of genes (Yang
et al., 2006). To understand the molecular basis of
‘‘stemness,’’ it will be important to distinguish which
p63-regulated genes contribute to proliferative potential
versus those maintaining tissue-specific functions in the
stem cell niche or forestalling differentiation.
While Bmi-1, Plzf, and p63 might act in analogous ways
to control genetic programs in stem cells, they clearly
function independently of one another. For instance, epi-
thelial tissues dependent on p63 do not require Bmi-1,
and, likewise, hematopoietic and neural stem cells are un-
affected by the absence of p63 (van der Lugt et al., 1994;
Yang et al., 1999; Senoo et al., 2004). Nevertheless, main-
taining a state of high proliferative potential in diverse cell
types would seem to require common strategies to avert
differentiation and senescence while enabling remarkably
extensive programs of cell division. Therefore, a major
challenge in stem cell biology will be to decipher the ge-
netic programs controlled by these lineage-specific regu-
lators and to understand whether they intersect at distal
levels. Toward this end, whole-genome analysis of physi-
cal p63 associations has revealed that this transcription
Figure 8. Model for the Role of p63 in the Maintenance of Epithelial Stem Cells
(A) A scheme for the role of p63 in epithelial stem cell maintenance. Wild-type progenitor cells (pro) give rise to both transit-amplifying (TA) cells and
stem cells in each cell division, which contributes to logarithmic expansion of epithelial tissues. In contrast, the absence of p63 leads to a decrease in
proliferative potential of epithelial progenitor cells, and consequently, these cells do not produce stem cells but produce TA cells with less proliferative
potential. The equations on the right indicate the total cell number at the division n. tn indicates the relative proliferation rate and can be estimated as
tn = 1  1/10n; D = relative increase in depletion from proliferating cell population in p63 null over wild-type epithelial cells.
(B) Analysis of relative proliferation of thymic epithelial cells during development. Immunofluorescence on thymus sections using anti-p63 (red) and
Ki67 (green) antibodies is shown. Arrows indicate examples of p63+/Ki67+ cells. Scale bar = 25 mm.
(C) Quantification of (B), expressed as the mean ± SD from three independent experiments.
(D) A mathematical model for thymic epithelial cell growth. Fold increase of the thymic epithelial cell number is plotted over ten cell divisions with
various losses of proliferating cells in each division. Inset is an actual observation of thymic epithelial cell growth during embryogenesis.
(E) A model for the loss of proliferating cells per cell division. The relative epithelial cell number (ratio) is plotted over losses of proliferating cells in each
division (D) with various doubling times. The relative number of epithelial cells in newborn p63 null embryos compared to wild-type is approximately
0.1 (see Figure S3).Cell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc. 533
factor directly binds nearly 2000 genes, including those
encoding adhesion, cell death, and stem cell signaling
molecules such as those involved in Notch, Wnt, and
TGF-b transduction cascades (Yang et al., 2006). This
finding suggests a broad and complex genetic program
underlying the stem cell state.
Finally, the notion of proliferative potential and question
of how it relates to stem cells and processes such as
tumorigenesis require further exploration (Reya et al.,
2001; Owens and Watt, 2003). How much overlap exists
in the genetic programs that support proliferative potential
in various cell types, and how do these programs compare
with those of immortalized cells in cancers? Answers to
these questions will help to solidify the molecular features
of ‘‘stemness’’ and contribute to strategies of regenerative
medicine and cancer therapeutics.
EXPERIMENTAL PROCEDURES
Animals
p63/ mice used in this study were backcrossed 10–12 times on
a BALB/c background. For staged embryos, the day of the vaginal
plug was designated E0.5. Sprague-Dawley rats were purchased
from Taconic. For in vivo proliferation assay, pregnant female mice
from p63+/ matings were injected intraperitoneally with 1 mg BrdU
3 hr prior to sample collection. Rag2/ reconstitution and T cell pro-
liferation assays are described in Supplemental Experimental Proce-
dures. Animals were handled in accordance with the Guidelines for
Animal Experiments at Harvard Medical School.
Epithelial Stem Cell Culture
Mouse thymic epithelial cells (TECs) were cultured as described
(Ropke, 2002) with some modifications. Briefly, E17 mouse thymuses
were cultured in TEC medium (3 mg/ml insulin, 10 ng/ml cholera toxin,
20 ng/ml EGF in serum-free DMEM/Ham’s F12 1:1 medium with low
Ca2+ [0.033 mg/ml]) supplemented with 0.5 mg/ml hydrocortisone. Af-
ter 7 days, single-cell suspensions were prepared and cultured be-
neath a layer of 50% Matrigel (BD Biosciences). Enrichment of TECs
was confirmed by immunostaining using anti-cytokeratin (clone AE1/
AE3, NeoMarkers) and anti-pan-reticular fibroblast antibodies (clone
ER-TR7, Cedarlane). More than 98% of the cells were AE1/AE3+ and
ER-TR7. For the 3D colony assay, single TECs were cultured in
CnT-02 medium (CELLnTEC) containing 50% Matrigel.
Rat epithelial stem cells were prepared from SD1 rats and cultured
according to the method described for human epidermal keratinocytes
(Barrandon and Green, 1985, 1987). Briefly, single cells were cultured
on lethally irradiated 3T3-J2 fibroblasts in cFAD medium (5 mg/ml insu-
lin, 10 ng/ml EGF, 2 3 109 M 3,30,5-triiodo-L-thyronine, 0.4 mg/ml
hydrocortisone, 24 mg/ml adenine, 13 1010 M cholera toxin in serum-
free DMEM/Ham’s F12 3:1 medium) supplemented with 10% fetal
bovine serum, 10 U/ml penicillin, and 100 mg/ml streptomycin.
shRNA
Stem-loop oligomers were synthesized in sense and antisense direc-
tions corresponding to rat DNp63 at nucleotides 806–824 and human
DNp63 at nucleotides 566–584 and 787–795. The selected sequences
were subjected to a BLAST search against the genomic databases to
ensure the specificity of the sequence. Lentivirus production was car-
ried out as described (Rubinson et al., 2003), and the oligonucleotide
sequences are listed in Supplemental Experimental Procedures.
Imaging and Flow Cytometry
Frozen and paraffin-embedded sections were cut into 6 mm sections.
All imaging was done on an Axioskop 2 microscope with an AxioCam534 Cell 129, 523–536, May 4, 2007 ª2007 Elsevier Inc.HRc digital camera (Zeiss) or an Axiovert 200M microscope (Zeiss)
with a Hamamatsu ORCA-ER digital camera (Hamamatsu Photonics)
using AxioVision (Zeiss) and MetaMorph software (Universal Imaging).
For intracellular staining, the cells were fixed and permeabilized with
a 1:1 mixture of methanol and acetone at 4C for 20 min. The stained
cells were analyzed on a FACSCalibur system using CellQuest soft-
ware (BD Biosciences). The antibodies used in this study are detailed
in Supplemental Experimental Procedures.
Apoptosis Assays
The cell suspensions were analyzed by flow cytometry using the Apo-
Alert Annexin V-FITC Apoptosis Kit (BD Biosciences). Apoptosis was
further characterized on sections by TUNEL assay using the In Situ
Cell Death Detection Kit (Roche).
Expression Microarray Analysis
Biotin-labeled, amplified RNA was fragmented and hybridized on the
Affymetrix Mouse Genome 430 2.0 Array at the Harvard Medical
School Biopolymers Facility. Data from two independent experiments
were GC-RMA normalized, and differentially expressed genes were
identified using GeneSpring software (Silicon Genetics/Agilent Tech-
nologies). The oligonucleotide sequences for semiquantitative RT-
PCR are listed in Supplemental Experimental Procedures.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, one table, and eight figures and can be
found with this article online at http://www.cell.com/cgi/content/full/
129/3/523/DC1/.
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